4//SEC Filing
Clark Eliana 4
Accession 0000950170-25-002115
CIK 0001652130other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:16 PM ET
Size
16.0 KB
Accession
0000950170-25-002115
Insider Transaction Report
Form 4
Clark Eliana
EVP, Chief Technical Officer
Transactions
- Sale
Common Stock
2025-01-02$12.03/sh−556$6,689→ 71,470 total - Sale
Common Stock
2025-01-03$12.18/sh−7,422$90,400→ 64,048 total
Footnotes (2)
- [F1]Sale of 556 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2024.
- [F2]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001914448
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:16 PM ET
- Size
- 16.0 KB